Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding.

Nada Younes, Isabelle Bourdeau, Harold Olney, Paul Perrotte, Odile Prosmanne, Mathieu Latour, David Roberge, André Lacroix
{"title":"Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding.","authors":"Nada Younes,&nbsp;Isabelle Bourdeau,&nbsp;Harold Olney,&nbsp;Paul Perrotte,&nbsp;Odile Prosmanne,&nbsp;Mathieu Latour,&nbsp;David Roberge,&nbsp;André Lacroix","doi":"10.1530/EO-21-0031","DOIUrl":null,"url":null,"abstract":"<p><strong>Summary: </strong>Needle tract seeding is a potential, albeit rare, complication following transcutaneous biopsies, leading to the seeding of tumor cells along the path of the needle. Biopsies of adrenal masses are not routinely recommended and are only indicated, after exclusion of pheochromocytoma, when an adrenal metastasis of a primary extra-adrenal cancer is suspected or when pathological confirmation of inoperable adrenocortical cancer (ACC) may impact treatment. Despite guideline recommendations to avoid primary adrenal biopsy, very few needle tract seeding cases have been reported and none were in the context of an ACC. We report the occurrence of needle tract seeding in a patient following adrenal transcutaneous biopsy leading to ACC abdominal wall recurrence.</p><p><strong>Learning points: </strong>Needle tract seeding is a rare complication of transcutaneous biopsy. It may increase morbidity and impact overall survival. It has yet to be documented in adrenocortical carcinoma (ACC).Adrenal masses can be accurately evaluated for malignancy using a combination of conventional and metabolic imaging, such as CT and fluorodeoxyglucose-PET, obviating the need for biopsies.Adrenal mass biopsy is not indicated in ACC unless advanced ACC is diagnosed, and a pathological confirmation would impact management.</p>","PeriodicalId":72907,"journal":{"name":"Endocrine oncology (Bristol, England)","volume":"1 1","pages":"K7-K12"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265540/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine oncology (Bristol, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1530/EO-21-0031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Summary: Needle tract seeding is a potential, albeit rare, complication following transcutaneous biopsies, leading to the seeding of tumor cells along the path of the needle. Biopsies of adrenal masses are not routinely recommended and are only indicated, after exclusion of pheochromocytoma, when an adrenal metastasis of a primary extra-adrenal cancer is suspected or when pathological confirmation of inoperable adrenocortical cancer (ACC) may impact treatment. Despite guideline recommendations to avoid primary adrenal biopsy, very few needle tract seeding cases have been reported and none were in the context of an ACC. We report the occurrence of needle tract seeding in a patient following adrenal transcutaneous biopsy leading to ACC abdominal wall recurrence.

Learning points: Needle tract seeding is a rare complication of transcutaneous biopsy. It may increase morbidity and impact overall survival. It has yet to be documented in adrenocortical carcinoma (ACC).Adrenal masses can be accurately evaluated for malignancy using a combination of conventional and metabolic imaging, such as CT and fluorodeoxyglucose-PET, obviating the need for biopsies.Adrenal mass biopsy is not indicated in ACC unless advanced ACC is diagnosed, and a pathological confirmation would impact management.

Abstract Image

Abstract Image

Abstract Image

肾上腺皮质癌复发后,最初的经皮活检:一个罕见的演示针道播种。
摘要:针道播种是经皮活检后潜在的并发症,虽然罕见,但会导致肿瘤细胞沿针道播种。肾上腺肿块活检不被常规推荐,只有在排除嗜铬细胞瘤后,当怀疑原发性肾上腺外癌的肾上腺转移或病理证实不能手术的肾上腺皮质癌(ACC)可能影响治疗时,才需要进行活检。尽管指南建议避免原发性肾上腺活检,但很少有针道播种病例被报道,而且没有一例是在ACC的背景下。我们报告在肾上腺经皮活检导致ACC腹壁复发的患者发生针道播种。学习要点:针道播种是经皮活检的罕见并发症。它可能增加发病率和影响总生存率。在肾上腺皮质癌(ACC)中尚未发现。使用常规和代谢成像(如CT和氟脱氧葡萄糖- pet)相结合,可以准确评估肾上腺肿块是否为恶性肿瘤,从而避免了活检的需要。除非诊断为晚期ACC,否则不需要肾上腺肿块活检,病理确认将影响治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信